The June 2026 issue of the African Journal of Pharmaceutical and Herbal Research highlights an important transition in pharmaceutical and herbal research across Africa: the shift from documenting traditional medicinal knowledge to generating rigorous scientific evidence to support pharmaceutical innovation and rational healthcare.

The contributions published in this issue collectively demonstrate that medicinal plants should no longer be viewed solely as components of traditional practice but rather as valuable sources of biologically active compounds that require systematic pharmacological, toxicological, microbiological, and pharmaceutical investigation.

This issue opens with a comprehensive review examining the ethnopharmacological relevance of Moringa oleifera in African livestock systems. By linking phytochemical evidence with veterinary applications, the review identifies the translational gap between traditional ethnoveterinary practices and standardized evidence-based protocols, highlighting an important direction for future research.

The challenge of antimicrobial resistance is addressed through two complementary original investigations. One explores synergistic and antagonistic interactions among selected Zimbabwean medicinal plant combinations against Neisseria gonorrhoeae, illustrating that rational combination design may provide opportunities for improving antimicrobial efficacy while also emphasizing that combining multiple plant extracts does not necessarily enhance biological activity. Another study evaluates the antibacterial activity of aqueous and ethanolic extracts of Annona muricata, further supporting the continued search for plant-derived antimicrobial agents against multidrug-resistant pathogens.

Safety evaluation remains equally important in herbal medicine research. The investigation of citrulline-rich extracts from Citrullus lanatus rind demonstrates that naturally derived products may exhibit both beneficial and potentially adverse biological effects depending on dose and duration of exposure. Such findings reinforce the necessity of comprehensive toxicological assessment before widespread therapeutic application.

Finally, the Nauclea latifolia study demonstrates an important step in translating traditional medicinal knowledge into a prototype herbal oral-care formulation supported by preliminary scientific evidence. Although further studies on stability, safety, efficacy, and quality standardization are required, the work provides a valuable foundation for future pharmaceutical development.

Taken together, these contributions reflect the multidisciplinary nature of modern pharmacognosy, where ethnobotany, phytochemistry, microbiology, toxicology, pharmacology, and pharmaceutical technology converge to advance evidence-based phytomedicine. They also remind us that the future of herbal medicine depends not merely on identifying biologically active plants, but on establishing quality, safety, efficacy, and reproducibility through rigorous scientific investigation.

On behalf of the Editorial Board, I extend my sincere appreciation to our authors and reviewers for their valuable contributions to this issue. We trust that the work presented here will stimulate further collaborative research and contribute to the development of safe, effective, and scientifically validated herbal medicines that address healthcare challenges in Africa and globally.